Front. Pediatr.Frontiers in PediatricsFront. Pediatr.2296-2360Frontiers Media S.A.10.3389/fped.2025.1640136PediatricsRetractionRetraction: ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathwayFrontiers Editorial Office*
Approved by: Jordi Pérez-Tur, Spanish National Research Council (CSIC), Spain
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
section-at-acceptanceGenetics of Common and Rare DiseasesA Retraction of the Original Research Article ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway By Ding Z, Yu F, Sun Y, Jiao N, Shi L, Wan J and Liu Q (2022). Front. Pediatr. 9:708555. doi: 10.3389/fped.2021.708555
The journal retracts the 16 February 2022 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
This retraction was approved by the Chief Editors of Frontiers in Pediatrics and the Chief Executive Editor of Frontiers. The authors agree to this retraction.